Search Results

Radiometer, a leading medical device company specializing in acute care testing solutions, and Etiometry, a leader in clinical decision-support software for critical care, announced a new commercial partnership to enhance clinical decision making and workflows in hospital settings.

Etiometry, the leader in clinical decision-support software, announced its IVCO2 Index™ was cleared by the Food and Drug Administration for use with neonatal ICU patients under 2kg, who are especially vulnerable to the effects of hypercapnia.

Etiometry, the leader in clinical decision-support software, shares exciting new study results from ten hospitals, including Boston Children’s Hospital, Children’s of Alabama, Children’s National Hospital and St. Louis Children’s Hospital, that demonstrate the significant impact its platform has on outcomes for critically ill patients.

Etiometry, the leader in clinical decision-support software for critical care, today announced CE Mark and Health Canada authorization of its IVCO2 Index™ for adult populations, which allows clinicians to visualize inadequate ventilation of carbon dioxide with other contextual data from the Etiometry Platform to help inform intervention decisions and get ahead of patient deterioration.

Etiometry , a leader in clinical decision-support software, announced today its IDO2 Index ™ was cleared for adult use by the Food and Drug Administration.

Etiometry , a leader in clinical decision-support software for critical care, announced today that the company has obtained the CE Mark under the European Union’s medical device regulation, marking the second adult and third pediatric market authorization.

Etiometry, a leader in clinical decision-support software for critical care, and Radiometer, a leading medical device company specializing in acute care testing solutions, announced a new collaboration to enhance the clinical workflows in Neonatal Intensive Care Units.

Etiometry , a leader in clinical decision-support software for critical care, announced today that it has doubled its FDA-cleared risk analytics portfolio to four indices, further strengthening its capability to track the fundamental pathways through which patients deteriorate under intensive care.

Etiometry’s Platform for Clinical Decision Support Software Earns 6 th FDA Clearance Newly cleared software updates based on feedback from platform’s clinician users

The American College of Cardiology Conference unveiled a first-of-its kind study evaluating the effect of a digital health platform based on registry data.